// App-Quantinova.ai

619 : Tebentafusp induced T and B cell epitope spread in patients with advanced melanoma

Researchers

Presenter

  • Alexander Greenshields Watson

Principal Investigators

  • Camille Britton-Rivet

  • Sarah Stanhope

  • Laura Collins

  • Koustubh Ranade

  • Adel Benlahrech

Medical Centers

  • Immunocore Ltd, Abingdon, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • GP100

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final